(Q47640171)
English
Prospective, Randomized, Double-Blind, Phase III Clinical Trial of Anti-T-Lymphocyte Globulin to Assess Impact on Chronic Graft-Versus-Host Disease-Free Survival in Patients Undergoing HLA-Matched Unrelated Myeloablative Hematopoietic Cell Transplan
scientific article published on 17 October 2017
Statements
1 reference
Prospective, Randomized, Double-Blind, Phase III Clinical Trial of Anti-T-Lymphocyte Globulin to Assess Impact on Chronic Graft-Versus-Host Disease-Free Survival in Patients Undergoing HLA-Matched Unrelated Myeloablative Hematopoietic Cell Transplan (English)
1 reference
David L Porter
1 reference
Jerome Ritz
1 reference
Laura Johnston
1 reference
Robert J Soiffer
1 reference
Haesook T Kim
1 reference
Joseph McGuirk
1 reference
Mitchell E Horwitz
1 reference
Mrinal M Patnaik
1 reference
Witold Rybka
1 reference
Andrew Artz
1 reference
Thomas C Shea
1 reference
Michael W Boyer
1 reference
Richard T Maziarz
1 reference
Paul J Shaughnessy
1 reference
Usama Gergis
1 reference
Hana Safah
1 reference
Ran Reshef
1 reference
John F DiPersio
1 reference
Patrick J Stiff
1 reference
Madhuri Vusirikala
1 reference
Jeff Szer
1 reference
Jennifer Holter
1 reference
James D Levine
1 reference
Paul J Martin
1 reference
Joseph A Pidala
1 reference
Ian D Lewis
1 reference
Vincent T Ho
1 reference
Edwin P Alyea
1 reference
Frank Glavin
1 reference
Peter Westervelt
1 reference
Madan H Jagasia
1 reference
Yi-Bin Chen
1 reference
17 October 2017
1 reference
1 reference
35
1 reference
36
1 reference
4003-4011
1 reference
Identifiers
1 reference
1 reference